Evidence map›Paper›PMID 24631201›Full record

ArticleJournal of cataract and refractive surgery2014

Effect of tamsulosin on iris vasculature and morphology.

Roni M Shtein, Munira T Hussain, Theresa M Cooney, Victor M Elner, Christopher T Hood

Open access · greenAbstract read
In one paragraph

Article in Journal of cataract and refractive surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Floppy iris syndrome associated with specific medication intake: A narrative review.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Roni M ShteinFrom the Department of Ophthalmology and Visual Sciences (Shtein, Hussain, Cooney, Elner, Hood), Kellogg Eye Center, and the Department of Pathology (Elner), University of Michigan, Ann Arbor, Michigan, USA. Electronic address: ronim@med.umich.edu.
Munira T HussainFrom the Department of Ophthalmology and Visual Sciences (Shtein, Hussain, Cooney, Elner, Hood), Kellogg Eye Center, and the Department of Pathology (Elner), University of Michigan, Ann Arbor, Michigan, USA.
Theresa M CooneyFrom the Department of Ophthalmology and Visual Sciences (Shtein, Hussain, Cooney, Elner, Hood), Kellogg Eye Center, and the Department of Pathology (Elner), University of Michigan, Ann Arbor, Michigan, USA.
Victor M ElnerFrom the Department of Ophthalmology and Visual Sciences (Shtein, Hussain, Cooney, Elner, Hood), Kellogg Eye Center, and the Department of Pathology (Elner), University of Michigan, Ann Arbor, Michigan, USA.
Christopher T HoodFrom the Department of Ophthalmology and Visual Sciences (Shtein, Hussain, Cooney, Elner, Hood), Kellogg Eye Center, and the Department of Pathology (Elner), University of Michigan, Ann Arbor, Michigan, USA.
University of Michigan–Ann Arbor · US

Funding

MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
Neovascularization Patterns in Corneal Graft RejectionK23EY017885 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHTEIN, RONI MINTZ · 2007 to 2011
$960k
NCRR NIH HHS UL1 RR024986NEI NIH HHS K23 EY017885
6 · The paper itself

Abstract

purposeTo determine whether preoperative iris vasculature and morphology are altered in patients who have taken tamsulosin (Flomax).

settingAcademic multispecialty practice.

designCase series.

methodsPatients with current or past tamsulosin use and age- and sex-matched control patients were included. Anterior segment optical coherence tomography (AS-OCT) and iris fluorescein angiography were performed to measure iris vasculature and thickness before cataract surgery. Data collected at surgery included pupil diameter, clinical signs of intraoperative floppy-iris syndrome, and surgical complications.

resultsTamsulosin was currently used by 16 patients and in the past by 4 patients; the control group comprised 10 patients. Pharmacologically dilated pupil diameter was statistically significantly smaller preoperatively and immediately postoperatively in the tamsulosin group than in the control group (P=.009 and P=.003, respectively). There was a statistically significant decrease in pupil size intraoperatively in the tamsulosin group (P=.05) but not in the control group (P=.3). Iris-vasculature parameters, specifically time to first vessel fill and percentage of vessel fill on iris fluorescein angiography, were not significantly different between the 2 groups. The AS-OCT measurements of iris morphology were not statistically significantly different between the groups. No surgical complications occurred. No fluorescein dye leakage, staining, or other vascular anomalies were observed.

conclusionsAlthough there were differences in pupil measurements and intraoperative iris behavior between patients who had been on tamsulosin and control patients, there were no significant differences in iris vasculature on iris fluorescein angiography or in iris morphology on AS-OCT.

Indexed as

Adrenergic alpha-1 Receptor AntagonistsAgedCase-Control StudiesCataract ExtractionCiliary ArteriesFluorescein AngiographyHumansIntraoperative ComplicationsIrisIris DiseasesMaleMuscle, SmoothProspective StudiesProstatic HyperplasiaPupilSulfonamidesAdrenergic alpha-1 Receptor AntagonistsSulfonamidesTamsulosin

Identifiers

PMID24631201
PMCPMC4392814
OpenAlexW2017259343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.